Lifecare AS (DE:LFC0) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Lifecare ASA, a medical sensor developer, announced promising results for its Sencell CGM system, showing clinical accuracy with a Mean Absolute Relative Difference (MARD) value of 9.6%, within the regulatory threshold for medical decision-making. The company will present its latest human pilot study results and upcoming development steps at the Diabetes Technology Meeting in California. This follows successful presentations of their technology at previous diabetes conferences, and the company is now advancing towards regulatory approval.
For further insights into DE:LFC0 stock, check out TipRanks’ Stock Analysis page.
